Organic Letters
Letter
V. Org. Lett. 1999, 1, 1183−1186. For OCON(TMS)-i-Pr, see:
(h) Kauch, M.; Hoppe, D. Can. J. Chem. 2001, 79, 1736−1746. For
1,5-O → N carbamoyl translocation, see: (i) Feberero, C.; Suarez-
Pantiga, S.; Cabello, Z.; Sanz, R. Org. Lett. 2018, 20, 2437−2440. For
carbamoyl Baker−Venkataraman reaction, a synthesis of chrome-
nones occurs. See: (j) Kalinin, A. V.; da Silva, A. J. M.; Lopes, C. C.;
Lopes, R. S. C.; Snieckus, V. Tetrahedron Lett. 1998, 39, 4995−4998.
For a recent excellent comprehensive review on AoF rearrangement,
see: (k) Korb, M.; Lang, H. Chem. Soc. Rev. 2019, 48, 2829−2882.
(5) Morin, J.; Zhao, Y.; Snieckus, V. Org. Lett. 2013, 15, 4102−4105.
(6) Regarding Kumada−Corriu cross coupling, see: (a) Sengupta, S.;
Leite, M.; Raslan, D. S.; Quesnelle, C.; Snieckus, V. J. Org. Chem.
1992, 57, 4066−4068. Quesnelle, C. A.; Snieckus, V. Synthesis 2018,
50, 4395−4412. Chemla, F.; Ferreira, F.; Perez-Luna, A.; Micouin, L.;
Jackowski, O. In Metal-Catalyzed Cross-Coupling Reactions and More;
de Meijere, A.; Brase, S.; Oestreich, M., Eds.; Wiley−VCH::
Weinheim, Germany, 2014; p 365. Regarding Suzuki−Miyaura
cross coupling, see: (b) Quasdorf, K. W.; Antoft-Finch, A.; Liu, P.;
Silberstein, A. L.; Komaromi, A.; Blackburn, T.; Ramgren, S. D.;
Houk, K. N.; Snieckus, V.; Garg, N. K. J. Am. Chem. Soc. 2011, 133,
6352−6363.
the meta-related OPO(NMe2)2 vs OMe combination undergoes in-
between metalation−methylation to afford product in 75% yield, but
this sequence must be performed at −105 °C. (e) For OP(O)(OEt)2,
Melvin also showed in-between metalation at −78 °C, followed by
phospha-AoF at 0 °C in 95% yield (see ref 9). (f) Knochel reported
that aryl OP(O)(NMe2)2 derivatives bearing meta-F, -Br, and -I
groups undergo magnesiation−iodine electrophile quench to afford
mixtures of 2- and 6-substituted products, see ref 15.
(21) Groom, K.; Hussain, S. M.; Morin, J.; Nilewski, C.; Rantanen,
T.; Snieckus, V. Org. Lett. 2014, 16, 2378−2381.
(22) (a) Corey, E. J.; Kwiatkowski, G. T. J. Am. Chem. Soc. 1966, 88,
5652−5653. (b) Corey, E. J.; Kwiatkowski, G. T. J. Am. Chem. Soc.
1968, 90, 6816−6821. (c) Corey, E. J.; Cane, D. E. J. Org. Chem.
1969, 34, 3053−3057.
1
(23) (a) Neither H NMR nor MS analysis gave distinguishable
peaks for integration, see SI. (b) From the product ratio 17:18 = ∼
2:1, it may be deduced that under 2.0 equiv of s-BuLi at −78 °C → rt
conditions, substrate is converted to 4A (72%) and 4B (28%) which,
since 4A requires double the amount of base, indicates consumption
of 1.65 equiv of the original 2.1 equiv of s-BuLi.
(24) In concurrence with our results, intermolecular competition
experiments at −105°C carried out by Watanabe established that the
OP(O)(NMe2)2 is approximately three- to four-fold stronger than the
OMOM, OCONEt2 and CONEt2 DMGs; see refs 13a and 13c.
(7) Melvin, L. S. Tetrahedron Lett. 1981, 22, 3375−3376.
(8) Cambie, R. C.; Palmer, B. D. Aust. J. Chem. 1982, 35, 827−837.
(9) Jardine, A. M.; Vather, S. M.; Modro, T. J. Org. Chem. 1988, 53,
3983−3985.
(10) (a) Dhawan, D.; Redmore, D. J. Org. Chem. 1984, 49, 4018−
4021. (b) Dhawan, D.; Redmore, D. J. Org. Chem. 1986, 51, 179−183.
(11) For reports of the use of OPO(NMe2)2 as DMG, see:
(a) Watanabe, M.; Date, M.; Kawanishi, K.; Tsukazaki, M.; Furukawa,
S. Chem. Pharm. Bull. 1989, 37, 2564−2566. (b) Date, M.; Kawanishi,
K.; Hori, T.; Watanabe, M.; Furukawa, S. Chem. Pharm. Bull. 1989,
37, 2884−2886. (c) Watanabe, M.; Date, M.; Kawanishi, K.; Hori, T.;
Furukawa, S. Chem. Pharm. Bull. 1990, 38, 2637−2643. (d) Watanabe,
M.; Date, M.; Kawanishi, K.; Hori, T.; Furukawa, S. Chem. Pharm.
Bull. 1991, 39, 41−48.
(12) (a) Legrand, O.; Brunel, J. M.; Constantieux, T.; Buono, G.
Chem. - Eur. J. 1998, 4, 1061−1067. (c) Legrand, O.; Brunel, J. M.;
Buono, G. Buono, G. Eur. J. Org. Chem. 1999, 1999, 1099−1105.
(d) Legrand, O.; Brunel, J. M.; Buono, G. Tetrahedron 2000, 56, 595−
603.
(13) (a) Clososki, G. C.; Rohbogner, C. J.; Knochel, P. Angew.
Chem., Int. Ed. 2007, 46, 7681−7684. (b) Rohbogner, C. J.; Clososki,
G. C.; Knochel, P. Angew. Chem., Int. Ed. 2008, 47, 1503−1507.
(c) Rohbogner, C. J.; Wirth, S.; Knochel, P. Org. Lett. 2010, 12,
1984−1987. For a recent study on a heterocyclic system, see:
Balkenhohl, M.; Heinz, B.; Abegg, T.; Knochel, P. Org. Lett. 2018, 20,
8057−8060.
(14) Blackburn, T.; Patel, J. J.; Alessi, M.; Snieckus, V. Org. Lett.
2020 accompanying Letter.
(15) For a sampling of significance as antioxidants, biologically active
molecules, and agrochemicals, see: (a) Toshiyuki, K.; Yoshinobu, S.;
Hironori, Y.; Kiyotaka, S. International Patent No. WO 2006126393,
2006. Feng, L.; Anbin, T.; Zigui, X.; Shiwen, L. Can. Patent No. CN
100999145, 2007. For use as flame retardants, see: (b) Qureshi, A.;
Hay, A. S. J. Chem. Res., Synop. 1998, 355. Keglevich, G.; Szelke, H.;
́
́
Kerenyi, A.; Kudar, V.; Hanusz, M.; Simon, K.; Imre, T.; Ludanyi, K.
Tetrahedron: Asymmetry 2005, 16, 4015−4021.
(16) Beak, P.; Brown, R. A. J. Org. Chem. 1977, 42, 1823−1824.
(17) Comins, D. L.; Brown, J. D. J. Org. Chem. 1986, 51, 3566−
3572.
(18) Cuevas, J.-C.; Patil, P.; Snieckus, V. Tetrahedron Lett. 1989, 30,
5841−5844.
(19) This compound can also be prepared in one step from POCl3.
See: Lyttle, M. H.; Satyam, A.; Hocker, D. M.; Bauer, K. E.; Caldwell,
C. G.; Hui, H. C.; Morgan, A. S.; Mergia, A.; Kauvar, L. M. J. Med.
Chem. 1994, 37, 1501−1507.
(20) For OMOM: (a) Winkle, M. R.; Ronald, R. C. J. Org. Chem.
1982, 47, 2101−2108. (b) For OCONEt2, see ref 4c. (c) For
CONEt2, see ref 4b. (d) For OPO(NMe2)2, Watanabe showed that
E
Org. Lett. XXXX, XXX, XXX−XXX